1126432-04-9

Basic information

• Product Name: (9aR)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride
• Synonyms: (9aR)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride;(9aR)-octahydropiperazino[2,1-c]morpholine dihydrochloride;(R)-OCTAHYDROPYRAZINO[2,1-C][1,4]OXAZINE;(9AR)-Octahydropyrazino[2,1-c][1,4]oxazine (hydrochloride)(1:2)
• CAS NO: 1126432-04-9
• Molecular Formula: C7H16Cl2N2O
• Molecular Weight: 215.12074
• Mol File: 1126432-04-9.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: (9aR)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: (9aR)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride(1126432-04-9)
• EPA Substance Registry System: (9aR)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride(1126432-04-9)

Safety Data

• Hazardous Substances Data: 1126432-04-9(Hazardous Substances Data)

Usage

Uses

Due to the lack of specific information on the applications of (9aR)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride, potential uses can only be hypothesized based on the general properties of oxazine compounds. These may include:
Used in Pharmaceutical Industry:
(9aR)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride could be used as a pharmaceutical agent for [specific medical condition or treatment] due to its potential biological activity and the fact that many heterocyclic compounds have been found to possess medicinal properties.
Used in Chemical Research:
In the field of chemical research, (9aR)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride may serve as a subject for studying the structure-activity relationships of heterocyclic compounds, contributing to the development of new drugs and materials.
Used in Material Science:
(9aR)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride might also be utilized in material science as a component in the development of new materials with unique properties, given the diverse applications of heterocyclic compounds in this field.

Upstream product

• 1126432-05-0 (9aR)-8-(phenylmethyl)octahydropyrazino[2,1-c][1,4]oxazine 
• 106973-37-9 (3S)-5-oxo-4-(phenylmethyl)-3-morpholinecarboxylic acid 
• 385802-30-2 (3S)-5-oxo-N,4-bis(phenylmethyl)-3-morpholinecarboxamide 
• 1089280-11-4 (9aS)-8-(phenylmethyl)hexahydropyrazino[2,1-c][1,4]oxazine-6,7-dione 
• 1089280-12-5 ethyl oxo((phenylmethyl){[(3S)-4-(phenylmethyl)-3-morpholinyl]methyl}amino)acetate 
• 1152110-17-2 1-phenyl-N-{[(3S)-4-(phenylmethyl)-3-morpholinyl]methyl}methanamine 
• 1089280-09-0 (3R)-5-oxo-N,4-bis(phenylmethyl)-3-morpholinecarboxamide 
• 106973-36-8 (3R)-5-oxo-4-(phenylmethyl)-3-morpholinecarboxylic acid 
• 1089280-13-6 (9aS)-8-(phenylmethyl)octahydropyrazino[2,1-c][1,4]oxazine 

Downstream Products

• 1152110-20-7 [(2R)-2-(cyclopentylmethyl)-3-(2-{5-fluoro-6-[(9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]-2-methyl-4-pyrimidinyl}hydrazino)-3-oxopropyl][(phenylmethyl)oxy]formamide 
• 1152107-25-9 GSK1322322 
• 1089759-42-1 (S)-octahydropyrazino[2,1-c][1,4]oxazine 

Relevant articles and documents

PEPTIDE DEFORMYLASE INHIBITORS

The present invention relates to {2-(alkyl)-3-[2-(5-fluoro-4-pyrimidinyl)hydrazino]-3- oxopropyl}hydroxyformamide compounds of Formula (I): or pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, processes for making and use of such compounds in the inhibition of bacterial peptide deformylase (PDF) activity and in treatment methods for bacterial infections

THIAZOLE SULFONAMIDE AND OXAZOLE SULFONAMIDE KINASE INHIBITORS

The present invention provides thiazole sulfonamide and oxazole sulfonamide compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents

THIAZOLE AND OXAZOLE KINASE INHIBITORS

The present invention provides thiazole and oxazole compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.

PEPTIDE DEFORMYLASE INHIBITORS

The present invention is directed to certain {2-(alkyl)-3-[2-(5-fluoro-4-pyrimidinyl)hydrazino]-3-oxopropyl}hydroxyformamide derivatives, compositions containing them, the use of such compounds in the inhibition of bacterial peptide deformylase (PDF) activity, and in the treatment of bacterial infections. Specifically, the invention is directed to compounds of formula (I), wherein R1, R2 and R3 are defined herein and to pharmaceutically acceptable salts thereof. The compounds of this invention are bacterial peptide deformylase inhibitors and can be useful in the treatment of bacterial infections.

Imidazopyridine Kinase Inhibitors

The present invention provides imidazopyridine compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.